Among First Companies to Natively Integrate Software Applications;
Gives Eclipsys Clients Choice and Lower Total Cost of Ownership
ATLANTA, Mar 29, 2010 (BUSINESS WIRE) –Following the momentum of launching an industry-defining open architecture platform, Eclipsys Corporation (NASDAQ: ECLP) today announced a partnership with Rothman Healthcare Research (Rothman) to build its Patient Condition Tracker software solution on the Helios by Eclipsys(TM) platform. The resulting native integration will give the Eclipsys hospital client base the option to utilize Rothman’s third-party patient condition monitoring tool in an integrated environment with the Eclipsys Sunrise Enterprise(TM) suite of solutions–without the additional time and expense typically required to interface disparate software applications.
“Eclipsys and Rothman share a long-standing relationship to improve patient care, and we both agree that the most effective way to achieve technology adoption in healthcare is through vendor neutrality,” said Daniel Rothman, executive vice president of Rothman Healthcare Research. “Rothman Healthcare Research was formed to turn a negative into a positive, developing our Patient Condition Tracker tool after a family member died from undetected complications following a medical procedure. The release of Helios by Eclipsys(TM) gives small dynamic companies like ours the enhanced ability to drive innovation in health information technology. There are many good ideas in the market, but hospitals are typically risk adverse for unknown applications from smaller vendors. The ability to have an open platform from an enterprise vendor like Eclipsys can accelerate the pace of innovation and adoption of newer, better ideas and offerings.”
Since 2004, Rothman Healthcare Research has been developing the Patient Condition Tracker to bridge the gaps in continuity of care. Rothman’s software application uses electronic health record (EHR) data to highlight subtle declines in patient health and immediately alert physicians in snapshot form. Patient records are coded in colors for nurses to more easily understand patient conditions. The software application is fed data from the hospital’s existing EHR system to generate and display a health score, based on vital signs, nursing assessments and lab results, in a user-friendly graphical format. The software also offers medical personnel the ability to see multiple patient graphs simultaneously for a high-level understanding of a whole unit.
“Rothman’s Patient Condition Tracker is an innovative solution that was specifically designed to help send more patients home safely,” said Philip M. Pead, president and chief executive officer of Eclipsys. “Yet in the risk-adverse healthcare industry, many hospitals have been reluctant to adopt a new technology from a smaller vendor, even though it could lead to better patient outcomes and workflow efficiencies. Rothman’s business story is a prime example of why we have opened up our platform to enable clients and companies to natively write applications. It delivers choice and great benefits to our clients who want to use the Rothman solution. It will eliminate the need for interfaces, lower the total cost of technology ownership and give their clinicians an additional monitoring tool to support patient safety.”
“We are excited to work with Rothman Healthcare Research,” added Pead, “Since we announced our Helios by Eclipsys(TM) platform on March 1, we have been approached by several hundred companies who have expressed an interest in integrating their applications on our platform. Eclipsys’ open architecture provides true choice for our clients and eliminates the need for cumbersome and costly interfaces.”
About Rothman Healthcare Research, LLC
Rothman Healthcare Research is committed to improving the quality and efficiency of patient care with innovative, patient-centric software that enables healthcare professionals to easily access critical and actionable patient health data. The Patient Condition Tracker generates a graph of patient condition that allows for greater continuity and quality of care while reducing costs. For more information, see http://www.rothmanhealthcare.com.
Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see http://www.eclipsys.com or email firstname.lastname@example.org.
To view more about Helios by Eclipsys(TM), see http://www.YouTube.com/EclipsysTV.
Statements in this news release concerning the scope of the agreement between Eclipsys and Rothman and features of and benefits provided by Eclipsys software and the application development by third parties, including Rothman, are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. The open platform initiative is new and untested in the market, and integration of third party systems will require additional development. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. The agreement between Eclipsys and Rothman can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys, Helios by Eclipsys, and Sunrise Enterprise are either registered trademarks or trademarks of Eclipsys Corporation (or its subsidiaries) in the United States and certain other countries. Other product and company names in this news release are or may be trademarks of their respective companies.
SOURCE: Eclipsys Corporation
Robin Wrinn, 404-847-5219
Director, Public Relations
Jason Cigarran, 404-847-5965
Vice President, Investor Relations
Rothman Healthcare Research:
Senior Director, Development